|
ATP2B4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.620900E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.864410E-02 |
| Normal-vs-Stage2 |
5.586300E-02 |
| Normal-vs-Stage3 |
3.224700E-03 |
| Normal-vs-Stage4 |
5.180000E-01 |
| Stage1-vs-Stage2 |
6.049400E-01 |
| Stage1-vs-Stage3 |
4.723600E-02 |
| Stage1-vs-Stage4 |
9.444400E-01 |
| Stage2-vs-Stage3 |
3.104600E-01 |
| Stage2-vs-Stage4 |
8.699000E-01 |
| Stage3-vs-Stage4 |
3.933400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.742990E-03 |
| Normal-vs-AfricanAmerican |
7.204200E-03 |
| Normal-vs-Asian |
8.905200E-01 |
| Caucasian-vs-AfricanAmerican |
4.975800E-01 |
| Caucasian-vs-Asian |
3.373600E-01 |
| AfricanAmerican-vs-Asian |
2.860800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.463600E-02 |
| Normal-vs-Female |
1.67007999999358E-05 |
| Male-vs-Female |
7.360400E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.635500E-02 |
| Normal-vs-Extreme_Weight |
1.115240E-01 |
| Normal-vs-Obese |
2.219500E-03 |
| Normal-vs-Extreme_Obese |
6.078800E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.357600E-01 |
| Normal_Weight-vs-Obese |
7.524200E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.794600E-01 |
| Extreme_Weight-vs-Obese |
9.012200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.302400E-01 |
| Obese-vs-Extreme_Obese |
3.818800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.855700E-02 |
| Normal-vs-Age(41-60Yrs) |
2.30289999999522E-05 |
| Normal-vs-Age(61-80Yrs) |
6.136300E-02 |
| Normal-vs-Age(81-100Yrs) |
9.045600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.343800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.988050E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.172750E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.460500E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.248500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.499800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.424570E-03 |
| Normal-VS-Type2 PRCC |
3.515800E-01 |
| Normal-VS-KIRP CIMP |
2.838300E-02 |
| Normal-VS-Unclassified PRCC |
1.638460E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.824600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.562390E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
8.335700E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.139800E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.711650E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.460400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.057000E-01 |
| Normal-vs-N1 |
1.326370E-02 |
| Normal-vs-N2 |
1.200230E-01 |
| N0-vs-N1 |
3.335700E-02 |
| N0-vs-N2 |
2.224200E-03 |
| N1-vs-N2 |
4.115800E-01 |
|
|
